Provided by Tiger Trade Technology Pte. Ltd.

PMV Pharmaceuticals

1.47
-0.0350-2.33%
Volume:275.40K
Turnover:410.68K
Market Cap:110.63M
PE:-1.04
High:1.54
Open:1.51
Low:1.46
Close:1.50
52wk High:1.91
52wk Low:1.02
Shares:75.51M
Float Shares:61.14M
Volume Ratio:0.27
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4131
EPS(LYR):-1.4800
ROE:-70.93%
ROA:-42.39%
PB:1.55
PE(LYR):-0.99

Loading ...

PMV Pharma Director Matthew Joseph Eckler Files Initial Beneficial Ownership Statement

Reuters
·
Oct 06

PMV Pharmaceuticals Adds Veteran Investor to Board

TIPRANKS
·
Oct 05

PMV Pharma Names Samsara BioCapital’s Matt Eckler to Board

Reuters
·
Oct 05

PMV Pharmaceuticals Appoints Matt Eckler, Ph.d., to Board of Directors

THOMSON REUTERS
·
Oct 05

PMV Pharmaceuticals, - Plans Nda Submission for Accelerated Approval of Rezatapopt in Q1 2027

THOMSON REUTERS
·
Oct 05

Press Release: PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors

Dow Jones
·
Oct 05

PMV Pharmaceuticals appoints Philip Herman as chief commercial officer

TIPRANKS
·
Sep 08

Press Release: PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

Dow Jones
·
Sep 08

PMV Pharmaceuticals Price Target Maintained with a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 04

PMV Pharmaceuticals Prices Oversubscribed $50.8 Million Offering

TIPRANKS
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Craig-Hallum Sticks to Their Buy Rating for PMV Pharmaceuticals (PMVP)

TIPRANKS
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Top Premarket Decliners

MT Newswires Live
·
Sep 01

Oncology Firm PMV Pharma Falls on $51 Mln Stock-and-Warrants Sale

Reuters
·
Sep 01

PMV Pharmaceuticals 42M share Spot Secondary priced at $1.21

TIPRANKS
·
Sep 01

Press Release: PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

Dow Jones
·
Sep 01

PMV Pharmaceuticals Reports Updated Rezatapopt Ovarian Cancer Data, Commences Offering

MT Newswires Live
·
Sep 01

PMV Pharmaceuticals Highlights Promising Phase 2 Ovarian Data

TIPRANKS
·
Sep 01

Oncology Co PMV Pharma Drops After Beginning Equity Offering

Reuters
·
Sep 01